Drawing based on the label description. No photo yet.
“Cefpodoxime Proxetil Tablets, USP 100 mg are light yellowish-orange, elliptical, film-coated tablets debossed with 'C' on one side and '61' on the other side”
C 61 pill
Pill with imprint C 61 is yellow, oval, 11 mm and has been identified as Cefpodoxime Proxetil 100 mg. It is used for bronchitis, sinus infections and urinary tract infections (UTIs). It is supplied by Nucare Pharmaceuticals,inc.
Cefpodoxime Proxetil 100 mg
- Imprint
- C 61
- Strength
- 100 mg
- Used for
- Bronchitis, sinus infections and urinary tract infections (UTIs)
- Color
- Yellow
- Shape
- Oval
- Size
- 11 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Nucare Pharmaceuticals,inc
- Drug class
- Antibiotic (cephalosporin)
- NDC
- 68071-2742, 16714-394, 68071-2742-1, 16714-394-01, 65862-095, 65862-095-20, 65862-095-01, 65862-095-99, 65862-095-25, 69043-006, 69043-006-01, 69043-006-25
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Cefpodoxime Proxetil used for?
Cefpodoxime Proxetil is used for bronchitis, sinus infections, urinary tract infections (UTIs) and pneumonia.
- Medicine type
- Antibiotic (cephalosporin)
Official uses from the US prescribing label
Cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Recommended dosages, durations of therapy, and applicable patient populations vary among these infections. Please see DOSAGE AND ADMINISTRATION for specific recommendations. Acute otitis media caused by Streptococcus pneumoniae (excluding penicillin-resistant strains), Streptococcus pyogenes, Haemophilusinfluenzae (including beta-lactamase-producing strains), or Moraxella (Branhamella) catarrhalis (including beta-lactamase-producing strains). Pharyngitis and/or tonsillitis caused by Streptococcus pyogenes. NOTE: Only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. Cefpodoxime proxetil is generally effective in the eradication of streptococci from the oropharynx. However, data establishing the efficacy of cefpodoxime proxetil for the prophylaxis of subsequent rheumatic fever are not available. Community-acquired pneumonia caused by S. pneumoniae or H. Influenzae (including beta-lactamase-producing strains). Acute bacterial exacerbation of chronic bronchitis caused by S. pneumoniae, H. influenzae beta-lactamase-producing strains only), or M. catarrhalis. Data are insufficient at this time to establish efficacy in patients with acute bacterial exacerbations of chronic bronchitis caused by beta-lactamase-producing strains of H. influenzae. Acute, uncomplicated urethral and cervical gonorrhea caused by Neisseria gonorrhoeae (including penicillinase-producing strains). Acute, uncomplicated ano-rectal infections in women due to Neisseria gonorrhoeae (including penicillinase-producing strains). NOTE: The efficacy of cefpodoxime in treating male patients with rectal infections caused by N. gonorrhoeae has not been established. Data do not support the use of cefpodoxime proxetil in the treatment of pharyngeal infections due to N. gonorrhoeae in men or women. Uncomplicated skin and skin structure infections caused by Staphylococcus aureus (including penicillinase-producing strains) or Streptococcus pyogenes. Abscesses should be surgically drained as clinically indicated. NOTE: In clinical trials, successful treatment of uncomplicated skin and skin structure infections was dose-related. The effective therapeutic dose for skin infections was higher than those used in other recommended indications. (See DOSAGE AND ADMINISTRATION.) Acute maxillary sinusitis caused by Haemophilusinfluenzae (including beta-lactamase-producing strains), Streptococcus pneumoniae, and Moraxella catarrhalis. Uncomplicated urinary tract infections (cystitis) caused by Escherichia coli, Klebsiellapneumoniae, Proteus mirabilis, or Staphylococcus saprophyticus. NOTE: In considering the use of cefpodoxime proxetil in the treatment of cystitis, cefpodoxime proxetil’s lower bacterial eradication rates should be weighed against the increased eradication rates and different safety profiles of some other classes of approved agents. (See CLINICAL STUDIES section.) Appropriate specimens for bacteriological examination should be obtained in order to isolate and identify causative organisms and to determine their susceptibility to cefpodoxime. Therapy may be instituted while awaiting the results of these studies. Once these results become available, antimicrobial therapy should be adjusted accordingly. To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefpodoxime proxetil tablets, and other antibacterial drugs, cefpodoxime proxetil tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
From the FDA-approved label on DailyMed (published Sep 14, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows C and the other side shows 61.
- It is yellow, oval, 11 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Cefpodoxime Proxetil
Inactive: Carboxymethylcellulose Calcium, Lactose Monohydrate, Hydroxypropyl Cellulose (1600000 Wamw), Sodium Lauryl Sulfate, Crospovidone (15 Mpa.s At 5%), Starch, Corn, Magnesium Stearate, Hypromellose 2910 (6 Mpa.s), Titanium Dioxide, Propylene Glycol, Fd&c Yellow No. 6, Ferric Oxide Yellow
Also distributed by
Northstar Rx LLC, Aurobindo Pharma Limited, Cronus Pharma LLC
Other pills with imprint C 61
Same imprint, different listing. Check the color, size and maker against your pill.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
50 M
Mirabegron 50 mg
Yellow, oval, 12 mm
Used for overactive bladder
-
BUMEX 1
Bumetanide 1 mg
Yellow, oval, 11 mm
Used for high blood pressure and heart failure
-
8 G1
Ondansetron 8 mg
Yellow, oval, 10 mm
Used for alcohol use disorder
-
FJ4
Tadalafil 20 mg
Yellow, oval, 12 mm
Used for high blood pressure in the lungs and vasculogenic impotence
-
I 52
Pantoprazole Sodium 40 mg
Yellow, oval, 12 mm
Used for acid reflux (GERD) and heartburn
-
A37
Pantoprazole 40 mg
Yellow, oval, 11 mm
Used for acid reflux (GERD) and heartburn
Other Cefpodoxime Proxetil pills
- A55 Cefpodoxime Proxetil 100 mg Orange, oval, 12 mm Used for bronchitis and sinus infections
- SZ 438 Cefpodoxime Proxetil 100 mg Orange, oval, 16 mm Used for bronchitis and sinus infections
- A57 Cefpodoxime Proxetil 200 mg Orange, capsule, 16 mm Used for bronchitis and sinus infections
- C 62 Cefpodoxime Proxetil 200 mg Red, oval, 15 mm Used for bronchitis and sinus infections
- SZ 439 Cefpodoxime Proxetil 200 mg Orange, oval, 16 mm Used for bronchitis and sinus infections